Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Yumanity Therapeutics (YMTX) News Today

Yumanity Therapeutics logo
JSPR Jasper Therapeutics, Inc.
Cara Therapeutics Inc CARA
Yumanity Therapeutics Inc.
Why Is Yumanity Therapeutics (YMTX) Stock Up Today?
Yumanity Therapeutics, Inc. stock logo
Yumanity Therapeutics (NASDAQ:YMTX) Upgraded to "Buy" by Zacks Investment Research
Zacks Investment Research upgraded Yumanity Therapeutics from a "hold" rating to a "buy" rating and set a $3.00 price target for the company in a research report on Tuesday.
Yumanity Therapeutics, Inc. stock logo
Yumanity Therapeutics, Inc. (NASDAQ:YMTX) Short Interest Down 61.4% in December
Yumanity Therapeutics, Inc. (NASDAQ:YMTX) was the target of a significant drop in short interest in December. As of December 15th, there was short interest totalling 61,200 shares, a drop of 61.4% from the November 30th total of 158,400 shares. Based on an average daily trading volume, of 175,700 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.9% of the shares of the stock are sold short.
Yumanity Therapeutics, Inc. (YMTX)
Yumanity: Q3 Earnings Snapshot
Get Yumanity Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for YMTX and its competitors with MarketBeat's FREE daily newsletter.

625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

YMTX Media Mentions By Week

YMTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

YMTX
News Sentiment

0.00

0.40

Average
Medical
News Sentiment

YMTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

YMTX Articles
This Week

0

0

YMTX Articles
Average Week

Get Yumanity Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for YMTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:YMTX) was last updated on 11/7/2024 by MarketBeat.com Staff
From Our Partners